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Effectiveness of participant recruitment strategies for critical care 
trials: a systematic review and narrative synthesis 
Abstract 
Background: Critical care trials are limited by problems with participant recruitment, and little is 
known about the most effective ways to enhance trial participation. Despite clinical research 
improving in the past decades within intensive care, participant recruitment remains a challenge. 
Not all eligible patients are identified, and opportunities for enrolment into clinical trials are often 
missed. Interventions to facilitate recruitment need to be identified to improve trial conduct in the 
critical care environment. Therefore, we aimed to establish the effectiveness of recruitment 
strategies in critical care trials in order to inform future research practice. 
Methods: Databases including Medline, Embase, CINAHL and PsychInfo were searched for English 
language papers from inception to February 2020.  The objectives were to: (a) establish the 
effectiveness of recruitment strategies; and (b) recommend how effective recruitment strategies can 
inform research practice. Two reviewers independently assessed papers for inclusion and critically 
appraised the quality of the studies. Discrepancies were discussed within the research team. 
Relevant data were extracted and thematically coded into five overarching themes using a narrative 
synthesis approach. The review was prospectively registered on PROSPERO (CRD42019160519). 
Results: The search resulted in 2509 initially identified articles, with 15 that met the inclusion 
criteria. Articles reported a combination of quantitative, mixed methods, and qualitative studies and 
a range of low, moderate, and high-quality studies. Although, in-keeping with narrative synthesis 
approaches, none were excluded based on methodological quality. Five themes were identified 
relating to: patient eligibility identification; who provides information and seeks consent; resource 
limitations; research culture or environment; and the consent model used. The relative success of 
recruitment strategies was dependent upon the experience and availability of the staff involved in 
the approach, trial design, the application of the strategy to the specific intensive care environment, 
the acceptability of the recruitment and consent models used, and the efficiency of the recruitment 
procedures. Opportunities for consent were missed in a proportion of eligible patients in most 
studies, suggesting that clinicians may avoid recruiting more complex patients or in more complex 
situations and that further development of strategies is needed. 
Conclusions: More effective recruitment strategies are required to enhance recruitment and the 
representativeness of the patient sample obtained in critical care trials, in order to expand the 
evidence-base for treatments in this field. Greater focus is needed on assessing the performance of 
different recruitment strategies within different types of studies and critical care research 
environments. Future resear h should e plore ke  stakeholders  e perie es of, and attitudes 
towards, recruitment and establish the most important and feasible modifiable barriers to 
recruitment. 
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Intensive care (or critical care) is a highly technical and specialised healthcare setting that provides 
treatment and support for critically ill patients with life-threatening conditions.1 There are 291,836 
critical care cases in the UK per year, and it accounts for a total proportion of 1% of NHS 
expenditure.2 However, despite intensive medical and nursing care, and provision of complex 
ventilatory and other organ support, in-hospital mortality rates are 23.9%.3 Whilst this is likely due 
to the critical condition of the patients admitted, treatment in critical care is lacking a robust 
evidence base. Despite considerable international research, many unanswered questions remain 
regarding the care of critically ill patients.4 One of the major limitations in conducting trials in this 
field is the difficulty of patient recruitment, however little is known about the most effective ways to 
enhance research participation.5 
Barriers to patient recruitment in critical care trials are heavily centred around the challenges of 
obtaining informed consent.6 Unlike other settings, researchers are limited in their interactions with 
patients due to illness severity, delirium, presence of sedatives and life-sustaining treatments. 
Additionally, patients in critical care often lack decisional capacity. Burns et. al found that 
approximately 90% of critical care patients are unable to make decisions regarding their inclusion in 
research, and most decisions will be made by representatives such as family members.6 Additionally, 
it can be difficult to identify family members to act as the patie t s surrogate decision-maker (SDM), 
and many will not know the patient s preferences and views about participation, increasing the 
difficulty in making a decision.7-9 
Not all critical care patients will have family members present, and the unavailability of a surrogate 
to provide consent by proxy may be as high as 40%.5, 6, 10 This is problematic for trials with narrow 
recruitment windows. Some studies have used deferred consent (research without prior consent) to 
achieve adequate recruitment in emergency situations, however some families have expressed 
concerns regarding the use of a deferred consent model.11 
Previous studies show that patient recruitment strategies in the wider context of clinical research 
are poorly defined.11 A Cochrane review exploring interventions to improve recruitment in 
randomised trials, 12 outlined the need for the research community to prioritise research into 
recruitment interventions.12, 13 Although the review authors identified useful methods, they only 
included recruitment interventions rather than recruitment strategies more broadly, and did not 
include other models of consent, therefore findings from the research are less applicable to critical 
care settings. For example, the optimisation of participant information leaflets is beneficial for 
recruitment, but may be of less benefit in a critical care context, due to the complexity of studies 
and a greater need for verbal explanation.11 Clinician involvement is variable in clinical research, and 
may contribute to patient refusal rates being as high as 20%,5, 6, 10 occurring more frequently in 
complex cases of care or cases involving elderly patients,6, 11 both of which are more likely in a 
critical care setting. Despite prior research evaluating recruitment interventions in non-critical care 
settings 12 and anecdotal and ad hoc reporting from critical care studies, there is limited evidence 
around the most effective strategies of participant recruitment in critical care. We conducted a 
systematic review and narrative synthesis to explore different recruitment strategies. The aim of this 
review was to systematically collate and synthesise published studies on recruitment strategies for 
critical care research. The objectives were to: (a) establish the effectiveness of recruitment 
strategies in critical care research; and (b) recommend how effective recruitment strategies can 
inform research practice. Based on a preliminary review of the literature, a narrative synthesis 
approach was chosen because there was expected to be wide heterogeneity between studies. Unlike 
reviews of solely qualitative or quantitative findings, for which other approaches to synthesis such as 
meta-ethnography or meta-analysis are appropriate, this approach can be used to textually 
su arise the data, e a li g data to tell a stor . 14  
Methods 
A systematic search methodology was used.15 The protocol was prospectively registered in the 
PROSPERO database (CRD42019160519). A narrative synthesis was performed in accordance with 
the Cochrane Collaboration guidance.16 
Eligibility criteria 
English language studies were included with no date restriction on the year of publication. 
Qualitative, quantitative and mixed-methods papers which reported the evaluation of a recruitment 
strategy within a critical care setting were eligible for inclusion. Papers e plori g li i ia s  or 
patie ts  attitudes to a spe ifi  re ruit e t strategy were also included. Critical care was defined 
according to the NHS Core Standards,17 as an area of medicine where patients receive more 
intensive monitoring and treatment for life threatening conditions. This includes high dependency 
units and intensive care units (ICUs) which are sometimes collectively known as critical care units.17 
Papers concerning patients in a critical care condition but not treated within a critical care setting 
were excluded. Papers reporting other aspects of research (such as retention of participants), 
describing disease criteria for selecting patients for inclusion into a trial and those which did not 
describe a specific strategy, were also excluded.  
Systematic search 
Four electronic databases (Medline, Embase, CINAHL and PsychInfo) were searched from inception 
to February 2020. Grey literature sources were also searched, and additional resources such as the 
ORRCA database (Online Resource for Recruitment Research in Clinical Trials).18 Additional papers 
were also found by searching the reference lists of key relevant papers (the pearl-growing 
technique). A search strategy (Figure 1) was developed with the support of a Subject Librarian and 
refined with key word search terms identified in titles and abstracts or using medical subject 
headi gs. Boolea  ter s O‘  a d AND  were used to search for key concepts in combination with 
each other. The search strategy comprised of strings for critical care, recruitment strategy and study 
design. The recruitment search string was adapted from Treweek et. al. Cochrane Collaboration 
systematic review.12 Papers from database searches were imported to EndNote X8. Titles and 
abstracts were then screened for relevance by one of the authors. Of these papers, 10%, were 
double screened by another author independently. Following de-duplication, those papers that met 
the inclusion criteria (n=98) were independently assessed for eligibility by two authors with reasons 
for exclusion recorded, in accordance with PRISMA guidance.15 Disagreements over eligibility of 
papers were resolved through discussion with a third author. 
[inset Figure 1] 
Figure 1. Example search strategy from Ovid MEDLINE. 
Critical appraisal 
The quality of included studies was assessed using tools relevant to study design (Mixed Methods 
Appraisal Tool 2018 version,19 appraisal tool for cross-sectional studies (AXIS)20 and Specialist Unit 
for Review Evidence 21 checklists) by one author. A 10% sample of studies was independently 
critically appraised by a second researcher. No papers were excluded based on methodological 
quality, in-keeping with narrative synthesis guidance.14 Any identified methodological issues arising 
within the studies was noted and considered during the data synthesis stage.  
Data extraction 
A data extraction tool was developed and piloted for this review. Extracted data included study aims, 
design, population, and setting. Information regarding the recruitment strategy used was also 
recorded, and the numbers of patients screened and/or recruited where reported. All data 
extraction was performed by one author, with data extraction for one study of each design 
(approximately 10%) independently performed by a second researcher. Data were entered into 
NVivo12 software to assist with coding and information retrieval.  
Data synthesis 
A narrative synthesis was performed following the approach proposed by Popay et. al.14 This is based 
on an iterative process with distinct stages. The first stage involved preliminary synthesis of findings, 
coding extracted data and organising it according to the research question. Inductive thematic 
analysis was performed, involving the extraction, coding, and organisation of data into appropriate 
overarching themes which were refined. Studies were reviewed again after this process to ensure 
that themes represented appropriate extracted data from all studies.  
Results 
Systematic search 
The database searches yielded 2,509 papers. An additional 17 papers were identified through other 
sources, resulting in a total of 2,526 records screened using title and abstract. After de-duplication, 
98 records were eligible for full-text assessment against the inclusion criteria and 15 papers6, 10, 22-34 
were subsequently included in the analysis (Figure 2). Study settings included the US (n=6), Canada 
(n=5), Australia (n=2), Europe (n=1) and North America (n=1). All except 4 papers were published 
between 2008 and 2019. The papers reported a combination of quantitative (n=13), mixed methods 
(n=1), and qualitative studies (n=1). Specific population characteristics included research staff,23 
patients receiving mechanical ventilation,22 stress ulcer prophylaxis,25 blood transfusions,25 fungal 
infection prevention,24 thromboprophylaxis,10 patients with sepsis,24-27, 30 acute respiratory distress 
syndrome,25 arterial or central venous lines,33 or traumatic brain injury,34 those eligible for various 
trials,32 and surrogate decision-makers (SDMs).28, 29, 31 Study characteristics are reported in Table 1.  
[insert Figure 2] 
Figure 2. PRISMA flow diagram.15 
Quality appraisal 
Studies were appraised based on whether they reported a clear statement of aims, justification of 
research methodology and clear explanation of the research design and recruitment strategy. 
Studies were of mixed quality and included some high-quality studies,6, 25, 27-31 although some were 
considered to be of medium to low quality due to a lack of methodological detail, non-reporting of 
recruitment processes or potential for non-response bias. These could be meaningful factors, as 
there may be an association between those who decline participation in critical care research, and 
those who are not approached for recruitment.  
[Insert Table 1] 
Table 1. Included study characteristics.  
 
Synthesis of findings 
Extracted data reported a wide range of recruitment strategies and were grouped according to the 
objectives of the review. Codes were grouped into five overarching themes, organised according to 
stages in the recruitment process which are outlined below: patient eligibility identification, nature 
of approach, resource limitations, research culture of environment, and consent model. Table 2 
provides examples of data coded at each theme. A conceptual map of the interactions and 
relationships between the strategies, recruitment barriers, and contextual factors was iteratively 
developed following discussion between the review team and is depicted in Figure 3.  
[Insert Table 2] 
Table 2. Overarching themes and examples.  
[Insert Figure 3] 
Figure 3. Conceptual map of the interrelation between key themes identified. 
Interventions to enhance eligibility identification  
Methods to identify trial eligibility ranged from in-person screening to the development and testing 
of electronic systems.24, 27, 29 The use of technology was found to reduce the time to identify eligible 
patients from 3 to 1 hour, and, in addition, identified more patients in a study comparing a sepsis 
alert tool vs manual screening.30 In one study, whi h used a sepsis s iffer  to s ree  routi e edi al 
data for eligible patients, the number of patients enrolled was doubled.27 However, electronic 
systems had high specificity, but compromised sensitivity and high false positives had to be filtered 
out by study coordinators, suggesting that tools required double-checking.27 Eligibility data could be 
reviewed remotely, reducing workload and reliance on paper-based charts.24, 30 However, the 
applicability of software to other electronic systems was limited by the available data, requiring 
specific search terms and relevant diagnostic criteria to capture eligible patients.24, 27  
In-person screening rounds allowed for reassessment of patients who might become eligible 
following initial screening and identification.32 In one study, manually screening the unit twice a day 
for 7-days, resulted in surrogate contact in a third of eligible patients. Recruitment was more likely 
on day one with availability decreasing each day.29 This approach was limited by the 2-hour 
screening window used daily, as patients with short stays or whose families visited briefly were 
excluded.29 
The use of screening logs to monitor recruitment was also found to be beneficial.33 In units that 
did t use s ree i g logs, re ruit e t rates were often lower and reasons for excluding patients 
were unclear in 10% of cases.33 Although monitoring was used as a solution to drive recruitment, 
screening logs required considerable investment of staff time.22, 25 However, their use was important 
for monitoring site performance, identifying obstacles to recruitment and evaluating co-enrolment 
where patients were enrolled in more than one concurrently operating trial.25 
Who provides information and seeks consent  
Six studies included information about who provided information about studies The consent 
approach was most often undertaken by research coordinators, meaning clinicians were 
infrequently involved in the process.6, 29, 33 In the Consent Study, consent was declined less often 
when sought by experienced researchers.6  
Additionally, the Approach Trial found that the duration of time between identifying an eligible 
patient, surrogate contact and consent being provided was similar regardless of whether the 
approach was made by a researcher or clinician.31 Most surrogates were satisfied with being 
approached for consent by research co-ordinators, and while SDMs perceived benefits to physician 
involvement, they thought their time was better allocated to attending to clinical duties.31 Although 
this dichotomisation between research and clinical roles may not be reflective of the increasing 
integration of clinical practice and research and was not explored in the study. The important role of 
nurses in the consent approach was also evident.32 Approaching potential participants with a dual 
approach involving the staff nurse giving basic information first and then more detailed trial 
information provided later by a researcher, was found to be useful in enhancing recruitment in Chlan 
et al s multi-site clinical trial.22   
Resource limitations and related recruitment barriers 
Unavailability of research staff limited recruitment, including for studies that used eligibility-
identification tools, 6, 27, 34 and where clinical staff were involved in the consent encounter.10 The 
Consent Study, which evaluated consent rates between different research scenarios, showed that 
57.3% of opportunities for consent from patients themselves or surrogates were either missed 
(28.8%) or not feasible due to operational reasons  (28.5%).6 In a minority of cases, missed patient 
recruitment was attributed to researcher workload, and this was more evident in patients with 
multiple clinical conditions.6  
Narrow recruitment windows contributed to a fifth of missed research opportunities,25 suggesting 
that recruitment benefits from trial designs which provide researchers with more time for 
identification and families with more decision-making time.6 In some cases, assessment of eligible 
patients did not occur until after 24 hours from initial identification. Such delays could occur when 
researchers assessed several patients in batches rather than immediately after identification.27 In 
one study, it was estimated that a quarter of extra eligible patients could have been enrolled if there 
was a more timely evaluation.27 
Additional recruitment hours , including during evenings, was associated with patient enrolment.6, 
27, 29 Expanded recruitment hours increased the number of proxies approached by one and a half 
times as much as daytime shifts alone, 23, 29, 33 despite the fact that family members being equally 
likely to be present on weekdays, evenings and weekends.29 The positive impact of additional hours 
was likely synergised by the regular presence of researchers.22, 29  
Lack of surrogate availability hindered recruitment,6, 28, 32, 33 with one study reporting the majority of 
patients having no visitors whatsoever.29 Surrogate availability was related to socioeconomic factors. 
Availability increased in patients of high median income, as well as in patients with a longer hospital 
stay.29 Surrogates were not always approached due to issues regarding family dynamics, confusion 
over who the surrogate is and their absence,6, 10, 29 and only a small proportion of patients had the 
legally authorised surrogate documented in the medical notes.6, 25, 29 
Research culture and environment  
Co-enrolment (where patients are simultaneously enrolled into more than one trial) was an 
identified strategy to maximise recruitment but was generally not used due to protocol prohibition 
and, as a method, was not widely supported by researchers.25, 32 Co-enrolment benefits include 
greater opportunity for research questions to be answered quickly, additional support for families, 
contributing positively to research participation.6 However, co-enrolment is complicated by the lack 
of guidance assisting selection when patients are eligible for multiple studies, with some researchers 
recruiting patients into the study with the lowest recruitment number.25 The Consent Study reported 
that some ICUs allowed co-enrolment as long as surrogate burden appeared low.6 Surrogates were 
often approached for a single study, however consent for multiple studies decreased as the number 
of studies that consent was requested for, increased. This demonstrated apprehension regarding 
multiple surrogate approaches.6  
Communication was essential to building confidence and trust with families which further increased 
likelihood of consenting.32 This included being known to the family, and staff who were professional, 
empathetic, positive, and took time to thoroughly explain the need for research and enrolment.10, 23 
Consent was also more likely if surrogates had adequate time to read and reflect on the patient 
information sheets.10, 25  Higher enrolment rates correlated with patients  of fa il  e ers  
awareness of the health issue being researched.33 Language barriers prohibited enrolment in some 
studies, with most units utilising translators but only a minority provided research documentation in 
another language.6, 25 
Promotion of research culture within the critical care environment and team cohesion was key to 
successful recruitment.10, 32 This could be promoted through weekly meeting updates, educational 
sessions and research coordinators providing feedback to staff addressing recruitment challenges.10, 
22, 25 The use of unit liaison staff aided in tailoring strategies to specific research priorities, balancing 
the needs of both patients and staff.22 Lack of awareness of research amongst junior staff in 
particular, made recruitment more difficult.6, 22 
Researcher experience was a predictor of fewer declined consents, providing a confounding 
explanation for increased enrolment in some studies.6, 27 Specific strategies that correlated with 
experience involved the assistance of a nurse counsellor during consenting encounters.22, 32 Staff 
training increased confidence in obtaining consent, which subsequently increased recruitment.10, 22  
Consent model used 
Different models of consent (from patients, surrogates, or deferred or waived consent) were 
described in a number of studies. First-person consent is considered to be the most ethically 
preferred model of informed consent for research in critical care, with critical care patients reporting 
that they provided consent due to a desire to help others.6 However, it is often problematic in 
critical care as most patients lack capacity to consent for themselves.6, 26, 32  
Surrogate-decision maker (SDM) consent, used in circumstances where patients lacked capacity to 
consent, was the most widely adopted approach. Surrogate consent prior to enrolment was more 
acceptable compared to consent sought following enrolment into the trial.6, 28, 35 Most surrogates 
consented as they believed their loved one could benefit, whilst those that declined had a desire to 
keep current treatment.6, 32 However, relying solely upon SDMs may bias the recruitment sample 
and is often time-consuming, making it unsuitable for trials with narrow recruitment windows.26, 28  
Deferred consent was used much less often than surrogate consent models.6 Few patients deemed it 
unacceptable, despite recognising surrogate absence as an important factor to impact the consent 
decision.28 Deferred consent requires consent to be sought retrospectively following the emergency 
from either the surrogate or the patient once recovered. However, is difficult to obtain deferred 
consent from the patient themselves, especially in studies characterised by high mortality or 
prolonged incapacity.28 However, a deferred consent approach may offer a timely alternative for 
trials where rapid initiation of an intervention is needed, providing specific ethical requirements are 
met. 
Waived consent, where no formal consent is obtained, was found to be effective in maximising 
recruitment.23, 26 Whilst a minority of patients considered deferred consent by surrogates as 
acceptable, few agreed to no consent whatsoever.6, 26, 28 Waived consent was considered by studies 
as a future avenue to maximise recruitment, but there are several notable issues surrounding its 
use.22, 26, 28 Waiving the need for a consenting signature specifically, was found to be useful in 
patients with peripheral muscle weakness.22 
There was an identified lack of formal evaluation of pre-emptive consent, (prior consent given 
before being identified as eligible for a study), with many just acknowledging the potential for its use 
in future situations.6, 28 In a hypothetical scenario of lost capacity, pre-emptive consent from patients 
or proxies was considered by patients to be more acceptable than deferred consent.28 
The Consent Study reported that the chosen consent model had an impact on the time interval 
between eligibility recognition and consent decision.6 Patient, family and clinician attitudes and 
preferences towards different approaches to obtaining consent, also governed the chosen method 
adopted by the primary research coordinator even if less efficient.6, 23, 25, 29  
  
Discussion 
Understanding the effectiveness of strategies to optimise research practice around recruitment in a 
critical care environment can help to expand the evidence-base for treatments for the most critically 
ill patients. In this review, identified studies were diverse in terms of research design and findings, 
but narrative synthesis has allowed the identification of a number of themes.   
Despite differences between study consent rates, our review has identified several modifiable 
factors which could affect the consenting process. Strategies to address the challenges around 
consent and who makes the initial approach showed that the most widely adopted approach was to 
seek consent by surrogates.6, 32, 35-38 The timeliest approach was deferred consent, however the use 
of this differed between studies and researchers  report discomfort in using this model.26, 39-41 
Whether the approach was by a researcher or clinician had no significant difference on consent 
rates, but characteristics of the approach such as rapport was found to affect participation.10, 23, 32 
This is supported by previous research which suggests that rather than the professional role or level 
of seniority of the person seeking consent, it is whether the person the delivering the trial 
information is approachable, trustworth , parti ipa t‐ e tred a d k owledgea le.42 
This review found that high staff workload and poor availability hindered the recruitment process, 
whilst researcher experience, increased recruitment hours, research team cohesion and familiarity 
of staff to research processes enhanced it.10, 22, 23, 32 Factors inherent to the study itself, such as 
recruitment windows and study protocol regulations, exacerbated existing recruitment issues.25 
These findings reflect previous research on strategies maximising recruitment in clinical research,12, 
43 however, application of these findings to critical care is limited by the inherent challenges of the 
environment and the need to rapidly administer life-saving treatments and interventions.5 
 Despite the introduction of a range of identification and screening strategies to improve 
recruitment, reasons for non-enrolment in the included studies were often unidentified. 25, 34 This 
highlights that research sites may benefit from better enrolment monitoring, and thus reduce 
potential bias.34 This is supported by the literature, stating that clinicians may subconsciously focus 
on specific patients and act favourably toward some study designs.24 They may also see their role as 
that of the patie t s prote tor, i ludi g from the perceived burdens of research, but in doing so 
they create barriers to the inclusion of potential research participants. 22 This role of gatekeepi g  i  
research, particularly where vulnerable populations are involved, is widely acknowledged in the 
previous literature.44  
The strengths of this review are that it includes quantitative, qualitative and mixed-methods 
research, allowing for a more thorough overview of current evidence. The review was conducted 
according to systematic review standards.15, 16 By including data regarding critical care recruitment 
strategies, the review attempts to narrate the different strategies and their surrounding factors.14 
The findings may also be relevant to other clinical settings and populations where there are 
particular recruitment challenges around obtaining consent from acutely unwell patients and trials 
involving time critical treatments such as emergency medicine research. 
Quality of evidence 
This review included some studies with poorer methodological quality (see Table 1. Included study 
characteristics). Study environments were diverse, with some considering specific sub-groups of ICU 
patients, although it was not possible to statistically assess heterogeneity due to the mixed- 
methods studies included in the review. However, themes were relatively consistent amongst 
studies considering the same type of recruitment strategy, with more rigorous studies contributing 
substantially to overall findings. Studies that evaluated recruitment approach or eligibility screening 
were prone to sampling bias, as participants were excluded due to surrogate unavailability or 
communication barriers.28, 32, 33 This limits the generalisability of the study findings. This is important 
because those from a higher socioeconomic group are more likely to have an available surrogate.29 
None of the included studies involved a randomised trial to evaluate the effectiveness of a 
recruitment strategy. 
A proportion of studies only included surrogate attitudes to consent models and approaches. This 
was problematic because pro ies  views towards acceptability of recruitment strategies are 
hara teristi all  differe t to patie ts  attitudes to o se t.38 Several studies focused on surrogate-
consent, despite being time-consuming, whilst evidence was limited on the use of other consent 
models6, 32, 35-38 despite them being widely used. 34, 36-38 Patient/participant views were 
underrepresented, due to the large proportion lacking capacity, meaning that direct participant 
views could not be ascertained unless through hypothetical scenarios. Variability between 
recruitment strategies in this review, limits generalisability to all critical care patients and 
populations. There may also be contextual factors relating to the differences in culture, legal 
frameworks, research personnel, healthcare systems and research infrastructure between countries, 
although this could not be meaningfully explored due to the relatively low numbers of studies from 
each region or country. Resource limitations meant that only English language articles were included 
in the synthesis.  
Conclusions 
Exploring different recruitment strategies is important for the effective conduct of trials in critical 
care. Adopted recruitment strategies differed between ICUs, dependent upon the characteristics of 
patients, proxies, the environment, and resources available. The most effective strategies for 
recruitment capacity, like deferred consent, may be problematic when considering participant 
satisfaction and attitudes. However, ensuring that patients who are unable to consent are included 
in trials is essential in order to develop evidence-based treatments for those who require critical 
care. 
Practical implications  
Recruitment strategies should be tailored to the specific ICU environment with a focus on 
embedding research in routine clinical practice and promoting a research culture in critical care 
units. Methodological implications include designing studies to avoid a narrow recruitment window 
where possible and ensuring careful consideration when selecting information provision and consent 
models and which personnel who will be making the approach. Future strategies to reduce decision-
maker burden include hybrid or dual consent models with staged information provision and consent, 
whereby research is introduced to the patient or surrogate and recruitment completed at a later 
time.31, 45 In critical care populations where there are complex barriers to informed consent, patient 
decision aids may be appropriate to enhance understanding,46 and support surrogate-decision 
makers.47 Adopting strategies to build trust and develop rapport with gatekeepers,44 and 
understanding clinician reluctance to enrol patients into trials,25 may improve recruitment. 
Opposition to co-enrolment requires further evaluation, to determine impact on trial validity.25 
Recommendations to enhance enrolment include monitoring decision making capacity, using 
consent processes that parallel study-risk and designing scalable multi-site strategies.48 
Areas for future research 
Greater consideration should be given to exploring specific contextual factors surrounding 
recruitment strategies and evaluate which modifiable barriers impact recruitment the most. Further 
qualitative studies within non-research active ICUs or those with lower levels of research activity 
may identify additional barriers to recruitment. Additionally, further research is required regarding 
surrogate, patient, and clinician-related factors that may introduce recruitment bias, and 
stakeholder attitudes towards approaching patients for consent to remain in the study once capacity 
is regained. Future studies should also seek to provide higher quality evidence about the 
effectiveness of recruitment strategies, such as through the use of multi-site randomised trials, 
improved reporting of recruitment processes, and exploration of potential response bias. 
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Table 2: Overarching themes and examples 
 
  
Overarching themes and their definition Example 
Interventions to enhance eligibility 
identification 
Identifying eligible participants is the first stage in the 
recruitment process and requires some form of 
screening. This can be in the form of technology using 
criterion-based systems, or by screening in-person to 
find potential study candidates.  
Technology use in the surgical ICU* led to 
time savings of more than 2 hours during 
this 2-week study. The total time consumed 
to screen eligible patients in the surgical 
ICU* fell from 207 minutes to 70 minutes. 
Annualised, this conservatively represents 
52 hours saved for a single coordinator in a 
single 15-bed ICU*.  29 
Research culture and environment 
Factors inherent to the unit environment enhance the 
performance of recruitment actions such as the 
awareness and promotion of research, good 
communication between staff and with patients, and 
researcher experience and confidence.  
A u er of the es ere ide tified he  
exploring family and surrogate-decision 
maker attitudes. These included personal 
responsibility, personal and patient values 
toward research, trust in the team and 
knowledge of the voluntary nature of 
participation.  30 
Consent model used 
Different ways of obtaining informed consent used 
within research have differing impacts on the success of 
recruitment, due to their suitability, acceptability, and 
practicality for use within a critical care environment.  
% of ICU* patients preferred consent by 
an SDM⁰ prior to enrolment, with 24% 
preferring a deferred consent model. 
Increasing the risk of harm of the study had 
o sig ifi a t i pa t o  patie ts’ preferred 
consent framework. p value=0.12 where 
p<0.0  as statisti ally sig ifi a t.  27 
Who provides information and seeks consent 
Approaching participants for informed consent may be 
performed by different members of staff, such as 
researchers, clinicians or nurses which has a subsequent 
impact on the willingness to participate. 
There as o differe e i  o se t rates 
based on the person who was approached 
for consent. 92% were approached by a 
research coordinator, of which 21% 
declined consent. 8% were approached by a 
clinician, of which 33% declined. p 
value=0.32 where p<0.05 was statistically 
sig ifi a t.  6 
Resource limitations and related recruitment 
barriers 
The ability to identify and approach patients for research 
is restricted by recruitment barriers such staff 
availability, recruitment hours and recruitment windows, 
in addition to external factors like surrogate availability. 
Addi g study staff to o er e e i g shifts 
increased the number of participants 
approached. 16% of eligible participants 
were approached with the addition of 
evening hours, compared to 10% 
approached during day-shift hours alo e. 32 
 
Figure 3. Conceptual map of the interrelation between key themes identified 
 
 
 
 
 
 
 
 
 
 
 
